Thomas Schall
CEO
Amgen Inc (AMGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas Schall
Thomas Schall is recorded as CEO at Amgen Inc (AMGN). Thomas Schall has spoken on 1 earnings call across 1 company, most recently for Amgen Inc on February 7, 2022.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Amgen Inc
Other people whose current roles at this company are on record from its filings.
- Robert Bradway CEO
- David W. Meline CFO
- Thomas Dittrich CFO
- David M. Reese, M.D. CTO
- Sean Bruich CTO
- Jonathan P. Graham General Counsel
- Linda H. Louie Chief Accounting Officer
- Matthew C. Busch Chief Accounting Officer
- Amy E. Miles Board Member
- Michael V. Drake Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.